Cargando…
Significance of post‐progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma
BACKGROUND AND AIM: Molecular‐targeted therapies such as sorafenib and lenvatinib have long been used as first‐line treatment for advanced hepatocellular carcinoma (aHCC). However, adverse events or limited therapeutic effects may necessitate the change to another therapeutic option, known as post‐p...
Autores principales: | Yano, Yoshihiko, Yamamoto, Atsushi, Minami, Akihiro, Momose, Kenji, Mimura, Takuya, Kim, Soo Ki, Hayashi, Hiroki, Kado, Takuo, Hirano, Hirotaka, Hirohata, Seiya, Yoon, Seitetsu, Nishi, Katsuhisa, Tei, Hiroshi, Tanaka, Hidenori, Oouchi, Sachiko, Matsuura, Takanori, Yasutomi, Eiichiro, Hatazawa, Yuri, Shiomi, Yuuki, Ueda, Yoshihide, Kodama, Yuzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218537/ https://www.ncbi.nlm.nih.gov/pubmed/35774348 http://dx.doi.org/10.1002/jgh3.12772 |
Ejemplares similares
-
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
por: Yano, Yoshihiko, et al.
Publicado: (2023) -
Eosinophilic Gastrointestinal Diseases: The Pathogenesis, Diagnosis, and Treatment
por: Kinoshita, Yoshikazu, et al.
Publicado: (2021) -
Histological diagnosis of polyploidy discriminates an aggressive subset of hepatocellular carcinomas with poor prognosis
por: Matsuura, Takanori, et al.
Publicado: (2023) -
PGC-1α regulates alanine metabolism in muscle cells
por: Hatazawa, Yukino, et al.
Publicado: (2018) -
E-Cadherin Is Transcriptionally Activated via Suppression of ZEB1 Transcriptional Repressor by Small RNA-Mediated Gene Silencing
por: Mazda, Minami, et al.
Publicado: (2011)